novo nordisk wegovy weight loss

News

Novo Nordisk Stock Jumps

Novo Nordisk Stock Jumps After Earnings. It Cuts Guidance as Weight-Loss Drug Sales Slow.

Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings even as sales of its blockbuster drugs Ozempic and Wegovy slowed, but cut its guidance for the year.

CNBC on MSN · 11h

Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast amid weaker sales of its blockbuster Wegovy weight loss drugs. Sales of the company's popular Wegovy obesity drug hit 17.

NJBIZ · 19h

Novo Nordisk seeks FDA approval for Wegovy weight loss pill

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 for obesity.

BioSpace3h

Novo Vows Smoother Market Waters for Wegovy—But Analysts Are Skeptical

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...

NBC New York8d

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%

Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and LifeMD to expand access to the blockbuster treatment now that ...

5don MSN

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

BioSpace2d

Novo’s Wegovy Inches Closer to Becoming First FDA-Approved GLP-1 Weight-Loss Pill

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results